<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Evaluation of sars-cov-2 antibody levels in pharmacists and pharmacy staff following corona vaccination. (vol 20, pg 347, 2023)

dc.contributor.authorÜnal, Güneş
dc.contributor.authorSezgin, Simla Dilara
dc.contributor.authorSancar, Mesut
dc.date.accessioned2024-07-04T08:06:38Z
dc.date.available2024-07-04T08:06:38Z
dc.date.issued2024
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Klinik Eczacılık Ana Bilim Dalı
dc.description.abstract[Abstract Not Available]
dc.identifier.citationÜnal, G., Sezgin, S. D. ve Sancar, M. (2024). Evaluation of sars-cov-2 antibody levels in pharmacists and pharmacy staff following corona vaccination. (vol 20, pg 347, 2023). Turkish Journal of Pharmaceutical Sciences, 21(1), 87. http://dx.doi.org/10.4274/tjps.galenos.2024.e001
dc.identifier.doi10.4274/tjps.galenos.2024.e001
dc.identifier.issn1304-530X
dc.identifier.issn2148-6247
dc.identifier.issue1
dc.identifier.startpage87
dc.identifier.urihttp://dx.doi.org/10.4274/tjps.galenos.2024.e001
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12695
dc.identifier.volume21
dc.identifier.wos001218393700001en_US
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.institutionauthorÜnal, Güneş
dc.language.isoen
dc.relation.ispartofTurkish Journal of Pharmaceutical Sciencesen_US
dc.relation.publicationcategoryDiğer
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectSARS-CoV-2
dc.subjectPharmacy
dc.subjectVaccination
dc.titleEvaluation of sars-cov-2 antibody levels in pharmacists and pharmacy staff following corona vaccination. (vol 20, pg 347, 2023)
dc.typeOther

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ünal-Güneş-2024.pdf
Size:
71.26 KB
Format:
Adobe Portable Document Format
Description:
Tam Metin / Full Text

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.44 KB
Format:
Item-specific license agreed upon to submission
Description: